Page last updated: 2024-11-07

androsterone and Adrenocorticotropic Hormone, Inappropriate Secretion

androsterone has been researched along with Adrenocorticotropic Hormone, Inappropriate Secretion in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Symptoms of hyperandrogenism are common in patients with Cushing's disease (CD), yet they are not sufficiently explained by androgen concentrations."1.7211-Oxygenated C19 steroids are the predominant androgens responsible for hyperandrogenemia in Cushing's disease. ( Adaway, JE; Auer, MK; Bidlingmaier, M; Braun, L; Hartmann, MF; Hawley, J; Keevil, B; Lottspeich, C; Nowotny, HF; Reincke, M; Reisch, N; Schilbach, K; Tschaidse, L; Vogel, F; Wudy, SA, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Nowotny, HF1
Braun, L1
Vogel, F1
Bidlingmaier, M1
Reincke, M1
Tschaidse, L1
Auer, MK1
Lottspeich, C1
Wudy, SA1
Hartmann, MF1
Hawley, J1
Adaway, JE1
Keevil, B1
Schilbach, K1
Reisch, N1

Other Studies

1 other study available for androsterone and Adrenocorticotropic Hormone, Inappropriate Secretion

ArticleYear
11-Oxygenated C19 steroids are the predominant androgens responsible for hyperandrogenemia in Cushing's disease.
    European journal of endocrinology, 2022, Nov-01, Volume: 187, Issue:5

    Topics: Adrenocorticotropic Hormone; Androgens; Androstenedione; Androsterone; Cortisone; Dehydroepiandroste

2022